• Published on: Sep 15, 2021
  • 5 minute read
  • By: Dr Rakesh Rai

Everything About Liver Function Tests- Purpose & Significance

  • WhatsApp share link icon
  • copy & share link icon
  • twitter share link icon
  • facebook share link icon

Everything About Liver Function Tests- Purpose & Significance

Liver function tests are medical laboratory tests that measure the number of various substances in the blood that are released into your blood by liver cells or made by your liver. These substances are often called "liver enzymes" because they are enzymes that are produced exclusively by the liver to help regulate metabolism for processing chemicals, nutrients, and drugs.

A high level of any one of these may suggest an abnormal situation involving your liver. The most common symptoms associated with a problem involving your liver include nausea, vomiting, yellowing skin color (jaundice), fever, and abdominal discomfort such as pain on gentle pressing around about halfway down on the right side of the abdomen.

A liver function test is a blood test that evaluates an individual's liver function or sees if there may be a problem in this organ. Liver functions including leukocyte count, alkaline phosphatase, ALT/AST enzymes, and bilirubin levels are measured with results interpreted by physicians who then advise treatment options to relieve pain or reduce the risk of liver disease. If the level of these agents is elevated then the physician will typically recommend further diagnostics such as antibody testing for hepatitis B and C infections, ultrasounds, and biopsies.

Liver function tests are a series of blood tests used to evaluate liver function. Tests may include the following:

  • Inclusion of serum albumin or total proteins as variables in the SMA12 test
  • Albumin fractional catabolic rate (ACR) and erythrocyte sedimentation rate (ESR) measurements, which can be used as a surrogate marker for changes in hepatocellular activity
  • Visible change is indicative that hepatocytes have been damaged or destroyed, an indicator that liver disease is present.
  • Fractional synthetic rate of albumin synthesis calculated from measurements of serum creatinine and urinary urea nitrogen providing information about hepatocyte intracellular mass status with decreased album

The most common of these are aminotransferases ALT and AST. These enzymes are released into the bloodstream in excessive amounts by the cells that line the bile ducts that carry bile from the liver - where it gets made - to where it gets used up in digestion ??i.e., all over your body, not just in your liver but also near your kidneys) when there's any sort of problem with those cells or with damage done to them because of some other hurtful event.

In the context of a medical lab test, a liver function test is anyone that has to do with the liver. Serum bilirubin, alanine aminotransferase (ALT), aspartate aminotransferase (AST), and alkaline phosphatase are common ones. A veterinarian could use ultrasound as well as biochemistry analysis. These tests show how well your liver is performing its duty to remove toxins from your body and to make bile for those toxins.  Liver function tests are conducted to assess the liver's ability to convert inactive substances in your blood to active ones.

Alanine aminotransferase (ALT/SGPT): tests what process - amino acid, carbohydrate, or fat - your liver is having trouble breaking down to store sugar for later use indigestion. This test will only show what type of enzyme the liver has difficulty processing at this time, so if this is normal but an alkaline phosphatase test comes back abnormal, this means there may be a different illness affecting the liver.

The test can measure certain chemicals that are released because of metabolism and excreted from the body in urine, such as albumin.

The most common indicators measured by blood-based liver function tests include GGT, ALP, total bilirubin / conjugated/unconjugated bilirubin, ALT and ASAT.

A group of enzymes found in healthy livers called GOT (gamma-glutamyl transpeptidase) and GPT (gamma-glutamyltransferase) can also be measured to determine damage to liver cells.

Liver Function Tests (LFTs) are a group of tests that measure the levels and function of various substances in the blood leave before digestion and within the liver. These include enzymes and proteins made by the liver; cholesterol, copper, iron, calcium, sodium, potassium; bilirubin level; albumin levels. The LFTs can be used to help diagnose many diseases such as viral hepatitis or alcoholic liver disease.

A history would normally prompt additional testing such as abdominal imaging for gallstones or metabolic abnormalities like cirrhosis caused by alcohol consumption. Kidney function should be tested because high-protein diets may cause kidney problems too. A genetic test might be warranted if there is a family history of inheritance. Liver function tests are a group of blood tests that doctors might use to evaluate the liver's ability to gather and store glycogen (sugar) and protein, produce bile, filter the blood, and produce cholesterol.

Drugs can accumulate in liver cells, leading to changes in levels of enzymes. Enzymes that are elevated may indicate an inflammatory or viral process as well as the use of certain medications such as steroids which need some time to clear from the body after discontinuation. The test isn't specific for any disease but can show if there is a liver problem even before symptoms occur, including cirrhosis and early hepatitis B and C infections. When first conducted, rapid elevations or decreases might be indications of acute injury or pre-clinically chronic injury respectively.

The liver may be the body's most important gland. It synthesizes nutrients from fat, carbohydrates, and protein into a form that can be absorbed by the blood to supply the cells, brain, and other tissues with a continuous supply of fuel. The liver also acts as a storage center for high-density energy reserves in times of food shortage or famine.

In response to viruses or bacteria which enter from our gut through their ingestion of contaminated water or insects’ excretions for example), substances called antibodies are manufactured in great numbers by specialized cells in an inflammatory reaction known as acute hepatitis. LFT helps measure the liver's endurance, by testing erythrocyte count, serum albumin level, bilirubin level and prothrombin time.

It's normal for your erythrocyte count to drop over time as you age. This is due mainly to the production of fewer red blood cells in your bone marrow. It may provide an indication of what is happening inside the liver with regard to the regeneration of new cells. An elevated or persistently high level can indicate cirrhosis or cancer. If it's persistently high, then requires radiologic imaging for diagnosis.

The liver function tests are blood tests that tell the physician how well the liver is working. The enzymes GGT, ALT, AST, and ALP are primarily tested to examine what should be healthy activities through three phases of hepatic metabolism. Since these enzymes exist primarily in the liver, they do not normally show up in any other tissue or fluid other than the bloodstream. If there is a disease that affects the cells within the liver, then inflammatory processes will ensue. This will lead to excessive production of oxygen-free radicals to facilitate cell death and release toxins into circulation which can affect all body systems including altering enzyme quantities, so they bump up against their normal reference ranges for evaluation.

The purpose of liver function tests is to diagnose and monitor a person's condition, based on levels of certain enzymes in the blood.

A high level of transaminases might be due to a variety of diseases or conditions, including hepatitis, cirrhosis, biliary obstruction from gallstones, or pancreatitis. Liver disease disrupting the production and release of albumin will also produce abnormally low-level albumin which can be detected with this test. A qualitative determination can be made if large amounts of Clotting Factor VIII are released into the bloodstream - Hepaetous Patina (HP) - leading to severe bleeding episodes independent from coagulation defects where plasma clotting normally should take place.

Liver function tests measure the level of different substances produced or used by the liver, such as albumin. The liver conditions may include fatty liver (hepatic steatosis), alcoholic hepatitis, cirrhosis, and many disorders affecting other parts of the body which ultimately damage the working capacity of your liver. Liver function tests are not meant to detect acute hepatitis or mild cases of elevated enzyme levels that commonly resolve on their own. Normal results suggest that there is no abnormality with your kidneys. Abnormal livers often show high amounts of creatinine kinase (CK) and alanine aminotransferase (ALT).

The liver is the body's only organ able to break down toxic compounds, so its function must be checked. The example you gave -- SGPT, or aspartate aminotransferase -- measures the level of a major liver enzyme. High levels could indicate damage from drugs also used for weight loss, such as acetaminophen/paracetamol (Tylenol) or metformin (Glucophage). Too-low levels of hepatocyte enzymes mean that the liver's not functioning properly and may develop complications like hepatitis and cirrhosis.

Read Blog
Wearable Health Monitoring India Market: Tracking Wellness & Chronic Care | SecondMedic

Wearable Health Monitoring India Market: Tracking Wellness & Chronic Care | SecondMedic

In India, wearable health monitoring is no longer a nice-to-have accessory - it’s becoming central to how people manage wellness, chronic conditions and preventive care. With the rise of lifestyle diseases, increasing smartphone penetration and growing consumer health awareness, the wearable health monitoring market is gaining serious momentum.

Market Size & Growth Outlook

According to a detailed study, the Indian wearable medical devices market generated approximately USD 2,344.5 million (USD 2.34 billion) in 2024 and is projected to reach USD 5,670.6 million by 2030, growing at a compound annual growth rate (CAGR) of about 16?tween 2025 and 2030. Grand View Research
Another research source puts the medical wearables market in India at USD 1.04 billion in 2024, forecast to reach USD 4.20 billion by 2033 at ~15.5?GR. IMARC Group

These figures underscore a major shift: wearables are becoming an integral part of India’s health-tech ecosystem - not just fitness gadgets, but devices capable of monitoring heart-rate, sleep, activity, arrhythmia, vitals, and enabling remote patient monitoring.

Why This Growth Is Happening

  • Chronic disease burden: With rising incidences of diabetes, hypertension, cardiovascular disease and obesity, there’s a greater demand for continuous monitoring and early alerts.
     

  • Digital health push: Government programmes like the National Digital Health Mission (NDHM) and greater smartphone/internet penetration support connected health solutions.
     

  • Consumer awareness & wellness culture: More Indians are adopting health-tech and wearables as part of lifestyle, not just for tracking steps but for meaningful health insights.
     

  • Home-based care & remote monitoring: The pandemic accelerated acceptance of home-based diagnostics and monitoring - making wearables more relevant for remote care models.
     

  • Device innovation & cost reduction: Improved sensors, cheaper manufacturing and localised device assembly are easing access and lowering barriers for adoption.
     

Segmentation & Key Areas of Impact

  • Product type: Smartwatches, fitness bands, smart rings, medical-grade monitors for vitals, remote patient monitoring sensors. For instance, the broader smart wearable market in India shows health & fitness tracking made up ~54.35% of the market in 2024. Mordor Intelligence+1
     

  • Application: Chronic disease monitoring, preventive wellness, senior care, remote patient monitoring. The largest revenue segment in 2024 is chronic disease management. Grand View Research
     

  • Geography & access: Urban metros lead adoption today but Tier-2/3 towns and rural areas represent the next frontier, especially when paired with telehealth and wearable-data integration.
     

How SecondMedic Fits In

At SecondMedic, we believe monitoring is as important as diagnostics - and wearables are key to that vision. Our platform integrates wearable-generated data into our digital health ecosystem so we can provide:

  • Continuous monitoring for individuals managing chronic conditions - enabling earlier interventions when trends suggest risk.
     

  • Preventive insights for health-conscious users - wearable data feeds into our dashboards to flag deviations and prompt doctor consults.
     

  • Remote care models for seniors or mobility-limited users - wearable alerts tie into tele-consultation and remote monitoring workflows.
     

  • Data-driven coaching - using wearable metrics (sleep, activity, heart-rate variability) to personalise lifestyle recommendations and follow-up plans.
     

By combining wearable health monitoring with virtual consultations, diagnostics and preventive screening, SecondMedic offers a holistic digital health solution - not just episodic care but continuous well-being.

Challenges Ahead

Despite strong growth, wearable health monitoring in India faces some headwinds:

  • Affordability & accessibility: While top-tier wearables are affordable for many urban users, the device cost and ecosystem (apps, data, follow-ups) can be a barrier for rural and lower-income groups.
     

  • Device accuracy & clinical validation: Consumer-grade wearables may lack medical-grade accuracy. For serious clinical usage, device certification and integration with health records are required.
     

  • Data integration & usability: Wearable data alone isn’t enough - it needs to be integrated into clinical workflows, trusted by doctors and actionable.
     

  • Digital literacy & internet/connectivity: Rural areas and older populations may face challenges using wearables effectively or syncing data.
     

  • Regulatory and privacy issues: With health data being sensitive, wearables must ensure strong data security, interoperability and comply with frameworks like NDHM.
     

Real-World Calculation & Uptake Example

  • If the market grows from USD 2.34 billion in 2024 to USD 5.67 billion by 2030, that’s roughly a 2.4× increase in six years.
     

  • At 16?GR, wearable adoption is expected to double approximately every 4.5 years.
     

  • If chronic disease monitoring is the largest segment today, then targeting those affected by diabetes/hypertension (over ~100 million Indians) gives enormous addressable potential for wearable monitoring + telehealth.
     

  • For SecondMedic platform users: even if 1% of chronic-disease patients adopt wearables and remote monitoring via our service, that could represent hundreds of thousands of people nationwide - driving meaningful growth in preventive care utilisation.
     

Looking Ahead

As sensors get cheaper, wearables become more accurate and integrated with digital health platforms, we expect:

  • Wearables prescribed by doctors as part of home-care plans for chronic patients.
     

  • Insurance-linked models where usage of wearables triggers incentives or premium discounts.
     

  • Data ecosystems where wearable telemetry flows into platforms like SecondMedic, enabling predictive analytics, alerts and personalised care.
     

  • Greater rural uptake with low-cost devices, smartphone penetration and telehealth coupling.
     

Conclusion

The wearable health monitoring market in India is at an inflection point - moving from fitness gadgets to serious health-tech tools.
For health platforms like SecondMedic, this is a major opportunity: wearable data becomes another input in delivering continuous, personalised, preventive and remote care.

Because health isn’t just about testing now - it’s about monitoring, tracking, and intervening early.

Discover how SecondMedic integrates wearable health monitoring into your care journey at www.secondmedic.com

 

References

  • Grand View Research: India wearable medical devices market USD 2,344.5 million in 2024, projected USD 5,670.6 million by 2030. Grand View Research
     

  • IMARC Group: India medical wearables market USD 1.04 billion in 2024; projected USD 4.20 billion by 2033. IMARC Group
     

  • Mordor Intelligence: India smart wearable market – 54.35% of revenue from health & fitness in 2024; chronic-disease monitoring CAGR ~24.7%. Mordor Intelligence

See all

Live Doctor consultation
Live Doctor Chat

Download Our App & Get Consultation from anywhere.

App Download
call icon for mobile number calling and whatsapp at secondmedic